Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Massachusetts Institute of Technology
Research
MIT rejects Trump deal tying research money to certain demands
MIT has refused the Trump administration’s offer for prioritized funding if it complies with a set of demands—the first university to publicly do so.
Gabrielle Masson
Oct 10, 2025 1:12pm
RNA biotech Soufflé rises with $200M and Big Pharma partners
Oct 7, 2025 3:30pm
Cyclerion emerges from latest pivot as neuro biotech
Sep 24, 2025 4:15am
Florey launches with plan to keep our guts in check
Oct 1, 2024 7:00am
Adjuvants supercharge existing COVID-19 vaccines in mice
Sep 8, 2023 12:15pm
Novo Nordisk, Broad Institute to collab on diabetes
Sep 6, 2023 3:55pm
